Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Bristow

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/724-5453

    Collapse Research 
    Collapse research activities and funding
    R01HL048013     (BRISTOW, MICHAEL R.)May 1, 1993 - Feb 28, 2009
    NIH/NHLBI
    Genetic-Adrenergic Interactions in Myocardial Failure
    Role: Principal Investigator

    T32HL007822     (BUTTRICK, PETER N.)Jul 1, 1996 - Jun 30, 2019
    NIH/NHLBI
    Post Graduate Studies in Cardiovascular Research
    Role: Co-Principal Investigator

    R01HL061640     (BRISTOW, MICHAEL R.)Sep 21, 1998 - Aug 31, 2004
    NIH/NHLBI
    CONTRACTILE PROTEIN EXPRESSION IN FAILING HUMAN HEART
    Role: Principal Investigator

    R01HL071118     (BRISTOW, MICHAEL R.)Jul 1, 2002 - Jun 30, 2004
    NIH/NHLBI
    Dynamic Expression Profiling in the Intact Human Heart
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kalscheur MM, Saxon LA, Lee BK, Steinberg JS, Mei C, Buhr KA, DeMets DL, Bristow MR, Singh SN. Outcomes of Cardiac Resynchronization Therapy in Patients with Intermittent Atrial Fibrillation or Atrial Flutter in the COMPANION Trial. Heart Rhythm. 2017 Mar 17. PMID: 28323173.
      View in: PubMed
    2. Bristow MR. Genetic variation expressed in the brain may impact heart failure. Eur J Heart Fail. 2017 Mar; 19(3):324-325. PMID: 28251773.
      View in: PubMed
    3. Sucharov CC, Kao DP, Port JD, Karimpour-Fard A, Quaife RA, Minobe W, Nunley K, Lowes BD, Gilbert EM, Bristow MR. Myocardial microRNAs associated with reverse remodeling in human heart failure. JCI Insight. 2017 Jan 26; 2(2):e89169. PMID: 28138556.
      View in: PubMed
    4. Bristow MR, Sharma K, Assmann SF, Linas S, Gersh BJ, Grady C, Rice MM, Singh S, Boineau R, McKinlay SM, Greenberg BH. Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT. Eur J Heart Fail. 2016 Nov 21. PMID: 27873428.
      View in: PubMed
    5. Leary PJ, Bristow MR. Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure? J Am Coll Cardiol. 2016 Nov 01; 68(18):2029-2030. PMID: 27788859.
      View in: PubMed
    6. Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction. Circ Heart Fail. 2016 Oct; 9(10). PMID: 27656000.
      View in: PubMed
    7. Bristow MR, Saxon LA, Feldman AM, Mei C, Anderson SA, DeMets DL. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial. JACC Heart Fail. 2016 Jul; 4(7):521-35. PMID: 27289408.
      View in: PubMed
    8. Leary PJ, Tedford RJ, Bluemke DA, Bristow MR, Heckbert SR, Kawut SM, Krieger EV, Lima JA, Masri CS, Ralph DD, Shea S, Weiss NS, Kronmal RA. Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study. J Am Coll Cardiol. 2016 Apr 05; 67(13):1544-52. PMID: 27150686.
      View in: PubMed
    9. Bristow MR, Enciso JS, Gersh BJ, Grady C, Rice MM, Singh S, Sopko G, Boineau R, Rosenberg Y, Greenberg BH. Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations. JACC Basic Transl Sci. 2016 Apr; 1(3):180-189. PMID: 27747305.
      View in: PubMed
    10. Lindenfeld J, Cleveland JC, Kao DP, White M, Wichman S, Bristow JC, Peterson V, Rodegheri-Brito J, Korst A, Blain-Nelson P, Sederberg J, Hunt SA, Gilbert EM, Ambardekar AV, Minobe W, Port JD, Bristow MR. Sex-related differences in age-associated downregulation of human ventricular myocardial ß1-adrenergic receptors. J Heart Lung Transplant. 2016 Mar; 35(3):352-61. PMID: 26970472.
      View in: PubMed
    11. Bristow MR, Quaife RA. The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series). Pulm Circ. 2015 Sep; 5(3):415-23. PMID: 26401244.
      View in: PubMed
    12. Vehlow C, Kao DP, Bristow MR, Hunter LE, Weiskopf D, Görg C. Visual analysis of biological data-knowledge networks. BMC Bioinformatics. 2015 Apr 29; 16:135. PMID: 25925016.
      View in: PubMed
    13. Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, Bristow MR, Packer M, Wasserman SM, Braunstein N, Pitt B, DeMets DL, Cooper-Arnold K, Armstrong PW, Berkowitz SD, Scott R, Prats J, Galis ZS, Stockbridge N, Peterson ED, Califf RM. Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol. 2015 Apr 21; 65(15):1567-82. PMID: 25881939.
      View in: PubMed
    14. Depeursinge A, Chin AS, Leung AN, Terrone D, Bristow M, Rosen G, Rubin DL. Automated classification of usual interstitial pneumonia using regional volumetric texture analysis in high-resolution computed tomography. Invest Radiol. 2015 Apr; 50(4):261-7. PMID: 25551822.
      View in: PubMed
    15. Kao DP, Lowes BD, Gilbert EM, Minobe W, Epperson LE, Meyer LK, Ferguson DA, Volkman AK, Zolty R, Borg CD, Quaife RA, Bristow MR. Therapeutic Molecular Phenotype of ß-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy. Circ Cardiovasc Genet. 2015 Apr; 8(2):270-83. PMID: 25637602.
      View in: PubMed
    16. Feldman AM, She L, McNamara DM, Mann DL, Bristow MR, Maisel AS, Wagner DR, Andersson B, Chiariello L, Hayward CS, Hendry P, Parker JD, Racine N, Selzman CH, Senni M, Stepinska J, Zembala M, Rouleau J, Velazquez EJ, Lee KL. Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials. Cardiology. 2015; 130(2):69-81. PMID: 25592552.
      View in: PubMed
    17. Hinterberg MA, Kao DP, Bristow MR, Hunter LE, Port JD, Görg C. Peax: interactive visual analysis and exploration of complex clinical phenotype and gene expression association. Pac Symp Biocomput. 2015; 419-30. PMID: 25592601.
      View in: PubMed
    18. Leary PJ, Barr RG, Bluemke DA, Bristow MR, Kronmal RA, Lima JA, Ralph DD, Ventetuolo CE, Kawut SM. H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study. Ann Am Thorac Soc. 2014 Nov; 11(9):1379-86. PMID: 25295642.
      View in: PubMed
    19. Taylor MR, Sun AY, Davis G, Fiuzat M, Liggett SB, Bristow MR. Race, common genetic variation, and therapeutic response disparities in heart failure. JACC Heart Fail. 2014 Dec; 2(6):561-72. PMID: 25443111.
      View in: PubMed
    20. Bristow MR. Polymorphic variation in the G-protein beta-3 subunit gene and response to BiDil in A-HeFT: Basis for an African-American pharmacogenetic advantage to nitric oxide donor therapy? JACC Heart Fail. 2014 Dec; 2(6):558-60. PMID: 25306449.
      View in: PubMed
    21. Aleong RG, Sauer WH, Davis G, Bristow MR. New-onset atrial fibrillation predicts heart failure progression. Am J Med. 2014 Oct; 127(10):963-71. PMID: 24931393.
      View in: PubMed
    22. Le CH, Mulligan CM, Routh MA, Bouma GJ, Frye MA, Jeckel KM, Sparagna GC, Lynch JM, Moore RL, McCune SA, Bristow M, Zarini S, Murphy RC, Chicco AJ. Delta-6-desaturase links polyunsaturated fatty acid metabolism with phospholipid remodeling and disease progression in heart failure. Circ Heart Fail. 2014 Jan; 7(1):172-83. PMID: 24284026.
      View in: PubMed
    23. Fiuzat M, O'Connor CM, Gueyffier F, Mascette AM, Geller NL, Mebazaa A, Voors AA, Adams KF, Piña IL, Neyses L, Muntendam P, Felker GM, Pitt B, Zannad F, Bristow MR. Biomarker-guided therapies in heart failure: a forum for unified strategies. J Card Fail. 2013 Aug; 19(8):592-9. PMID: 23910590.
      View in: PubMed
    24. Aleong RG, Sauer WH, Sauer WH, Murphy GA, Port JD, Anand IS, Fiuzat M, O'Connor CM, Abraham WT, Liggett SB, Bristow MR. Prevention of atrial fibrillation by bucindolol is dependent on the beta1389 Arg/Gly adrenergic receptor polymorphism. JACC Heart Fail. 2013 Aug; 1(4):338-44. PMID: 24159564.
      View in: PubMed
    25. Feldman AM, Mann DL, She L, Bristow MR, Maisel AS, McNamara DM, Walsh R, Lee DL, Wos S, Lang I, Wells G, Drazner MH, Schmedtje JF, Pauly DF, Sueta CA, Di Maio M, Kron IL, Velazquez EJ, Lee KL. Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circ Heart Fail. 2013 May; 6(3):461-72. PMID: 23584092.
      View in: PubMed
    26. Bristow MR, Aleong RG. Treatment of the heart failure patient with atrial fibrillation: a major unmet need. JACC Heart Fail. 2013 Feb; 1(1):29-30. PMID: 24621796.
      View in: PubMed
    27. Aleong RG, Sauer WH, Robertson AD, Liggett SB, Bristow MR. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure. Circ Arrhythm Electrophysiol. 2013 Feb; 6(1):137-43. PMID: 23275278.
      View in: PubMed
    28. Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, Bristow MR. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail. 2013 Mar; 15(3):324-33. PMID: 23223178.
      View in: PubMed
    29. Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD. A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol. PLoS One. 2012; 7(11):e48184. PMID: 23144856.
      View in: PubMed
    30. O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Walsh R, Nelson P, Medway A, Davis G, Robertson AD, Port JD, Carr J, Murphy GA, Lazzeroni LC, Abraham WT, Liggett SB, Bristow MR. Combinatorial pharmacogenetic interactions of bucindolol and ß1, a2C adrenergic receptor polymorphisms. PLoS One. 2012; 7(10):e44324. PMID: 23071495.
      View in: PubMed
    31. Leary PJ, Barr RG, Bluemke DA, Bristow MR, Hough CL, Kronmal RA, Lima JA, McClelland RL, Tracy RP, Kawut SM. Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study). Am J Cardiol. 2012 Dec 15; 110(12):1846-51. PMID: 22995970.
      View in: PubMed
    32. Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)--right ventricle study. Circulation. 2012 Oct 02; 126(14):1681-8. PMID: 22932258.
      View in: PubMed
    33. Musunuru K, Roden DM, Boineau R, Bristow MR, McCaffrey TA, Newton-Cheh C, Paltoo DN, Rosenberg Y, Wohlgemuth JG, Zineh I, Hasan AA. Cardiovascular pharmacogenomics: current status and future directions-report of a national heart, lung, and blood institute working group. J Am Heart Assoc. 2012 Apr; 1(2):e000554. PMID: 23130127.
      View in: PubMed
    34. Bristow MR. Pharmacogenetic targeting of drugs for heart failure. Pharmacol Ther. 2012 Apr; 134(1):107-15. PMID: 22281236.
      View in: PubMed
    35. Mazzini M, Tadros T, Siwik D, Joseph L, Bristow M, Qin F, Cohen R, Monahan K, Klein M, Colucci W. Primary carnitine deficiency and sudden death: in vivo evidence of myocardial lipid peroxidation and sulfonylation of sarcoendoplasmic reticulum calcium ATPase 2. Cardiology. 2011; 120(1):52-8. PMID: 22116472.
      View in: PubMed
    36. Bristow MR. Treatment of chronic heart failure with ß-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology. Circ Res. 2011 Oct 28; 109(10):1176-94. PMID: 22034480.
      View in: PubMed
    37. Port JD, Bristow MR. Aptamer therapy for heart failure? Circ Res. 2011 Oct 14; 109(9):982-3. PMID: 21998296.
      View in: PubMed
    38. Fiuzat M, Bristow MR. Pharmacogenetics in heart failure trials. Heart Fail Clin. 2011 Oct; 7(4):553-9. PMID: 21925439.
      View in: PubMed
    39. Dockstader K, Nunley K, Karimpour-Fard A, Medway A, Nelson P, Port JD, Liggett SB, Bristow MR, Sucharov CC. Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the ß1-adrenergic receptor. Physiol Genomics. 2011 Dec 05; 43(23):1294-306. PMID: 21954455.
      View in: PubMed
    40. O'Connor CM, Fiuzat M, Swedberg K, Caron M, Koch B, Carson PE, Gattis-Stough W, Davis GW, Bristow MR. Influence of global region on outcomes in heart failure ß-blocker trials. J Am Coll Cardiol. 2011 Aug 23; 58(9):915-22. PMID: 21851879.
      View in: PubMed
    41. Sucharov CC, Dockstader K, Nunley K, McKinsey TA, Bristow M. ß-Adrenergic receptor stimulation and activation of protein kinase A protect against a1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5. J Card Fail. 2011 Jul; 17(7):592-600. PMID: 21703532.
      View in: PubMed
    42. Dibble CT, Lima JA, Bluemke DA, Chirinos JA, Chahal H, Bristow MR, Kronmal RA, Barr RG, Ferrari VA, Propert KJ, Kawut SM. Regional left ventricular systolic function and the right ventricle: the multi-ethnic study of atherosclerosis right ventricle study. Chest. 2011 Aug; 140(2):310-6. PMID: 21330384.
      View in: PubMed
    43. Feiner EC, Chung P, Jasmin JF, Zhang J, Whitaker-Menezes D, Myers V, Song J, Feldman EW, Funakoshi H, Degeorge BR, Yelamarty RV, Koch WJ, Lisanti MP, McTiernan CF, Cheung JY, Bristow MR, Chan TO, Feldman AM. Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. J Card Fail. 2011 Mar; 17(3):253-63. PMID: 21362533.
      View in: PubMed
    44. Bader FM, Gilbert EM, Mehta NA, Bristow MR. Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure. Congest Heart Fail. 2010 Nov-Dec; 16(6):265-70. PMID: 21091611.
      View in: PubMed
    45. Carson P, Fiuzat M, O'Connor C, Anand I, Plehn J, Lindenfeld JA, Silver M, White M, Miller A, Davis G, Robertson AD, Bristow M, Gottlieb S. Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (ß-Blocker Evaluation of Survival Trial [BEST]). Am Heart J. 2010 Oct; 160(4):649-54. PMID: 20934558.
      View in: PubMed
    46. Ventetuolo CE, Ouyang P, Bluemke DA, Tandri H, Barr RG, Bagiella E, Cappola AR, Bristow MR, Johnson C, Kronmal RA, Kizer JR, Lima JA, Kawut SM. Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):659-67. PMID: 20889903.
      View in: PubMed
    47. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol. 2010 Jul 27; 56(5):382-91. PMID: 20650360.
      View in: PubMed
    48. Murphy GA, Fiuzat M, Bristow MR. Targeting heart failure therapeutics: a historical perspective. Heart Fail Clin. 2010 Jan; 6(1):11-23. PMID: 19945056.
      View in: PubMed
    49. Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009 Dec; 30(24):3015-26. PMID: 19700774.
      View in: PubMed
    50. Bristow MR, Murphy GA, Krause-Steinrauf H, Anderson JL, Carlquist JF, Thaneemit-Chen S, Krishnan V, Abraham WT, Lowes BD, Port JD, Davis GW, Lazzeroni LC, Robertson AD, Lavori PW, Liggett SB. An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. Circ Heart Fail. 2010 Jan; 3(1):21-8. PMID: 19880803.
      View in: PubMed
    51. Calalb MB, McKinsey TA, Newkirk S, Huynh K, Sucharov CC, Bristow MR. Increased phosphorylation-dependent nuclear export of class II histone deacetylases in failing human heart. Clin Transl Sci. 2009 Oct; 2(5):325-32. PMID: 20443916.
      View in: PubMed
    52. Sumner AD, Boehmer JP, Saxon LA, Carson P, Feldman AM, Galle E, Bristow MR. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy. Congest Heart Fail. 2009 Jul-Aug; 15(4):159-64. PMID: 19627288.
      View in: PubMed
    53. Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, Guarnieri T, Rao A, Yong P, Galle E, Leigh J, Ecklund F, Bristow MR. Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol. 2009 Jul; 20(7):764-8. PMID: 19298563.
      View in: PubMed
    54. Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O'Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, Bristow MR. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation. 2009 Feb 24; 119(7):969-77. PMID: 19204305.
      View in: PubMed
    55. MacGregor JF, Wachter SB, Munger M, Stoddard G, Bristow MR, Gilbert EM. Carvedilol produces sustained long-term benefits: follow-up at 12 years. Congest Heart Fail. 2009 Jan-Feb; 15(1):5-8. PMID: 19187400.
      View in: PubMed
    56. Taylor MR, Slavov D, Humphrey K, Zhao L, Cockroft J, Zhu X, Lavori P, Bristow MR, Mestroni L, Lazzeroni LC. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure. Pharmacogenet Genomics. 2009 Jan; 19(1):35-43. PMID: 18953265.
      View in: PubMed
    57. Movsesian M, Stehlik J, Vandeput F, Bristow MR. Phosphodiesterase inhibition in heart failure. Heart Fail Rev. 2009 Dec; 14(4):255-63. PMID: 19096931.
      View in: PubMed
    58. Bristow MR, Hiatt WR. The FDA regulatory process for drug and genetic diagnostic test approvals. Clin Transl Sci. 2008 Dec; 1(3):188-9. PMID: 20443847.
      View in: PubMed
    59. Carnegie GK, Soughayer J, Smith FD, Pedroja BS, Zhang F, Diviani D, Bristow MR, Kunkel MT, Newton AC, Langeberg LK, Scott JD. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell. 2008 Oct 24; 32(2):169-79. PMID: 18951085.
      View in: PubMed
    60. Sharkey SW, Maron BJ, Nelson P, Parpart M, Maron MS, Bristow MR. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol. 2009 Feb; 53(1):53-7. PMID: 19167638.
      View in: PubMed
    61. Kline KG, Frewen B, Bristow MR, Maccoss MJ, Wu CC. High quality catalog of proteotypic peptides from human heart. J Proteome Res. 2008 Nov; 7(11):5055-61. PMID: 18803417.
      View in: PubMed
    62. Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol. 2008 Aug; 45(2):185-92. PMID: 18582896.
      View in: PubMed
    63. Haddad GE, Saunders LJ, Crosby SD, Carles M, del Monte F, King K, Bristow MR, Spinale FG, Macgillivray TE, Semigran MJ, Dec GW, Williams SA, Hajjar RJ, Gwathmey JK. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiol Genomics. 2008 Apr 22; 33(2):267-77. PMID: 18303083.
      View in: PubMed
    64. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail. 2008 Feb; 14(1):9-18. PMID: 18226768.
      View in: PubMed
    65. Sauer WH, Bristow MR. The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. J Interv Card Electrophysiol. 2008 Jan; 21(1):3-11. PMID: 18044015.
      View in: PubMed
    66. Metra M, Dei Cas L, Bristow MR. The pathophysiology of acute heart failure--it is a lot about fluid accumulation. Am Heart J. 2008 Jan; 155(1):1-5. PMID: 18082481.
      View in: PubMed
    67. Lowes BD, Zolty R, Shakar SF, Brieke A, Gray N, Reed M, Calalb M, Minobe W, Lindenfeld J, Wolfel EE, Geraci M, Bristow MR, Cleveland J. Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers. J Heart Lung Transplant. 2007 Nov; 26(11):1170-6. PMID: 18022084.
      View in: PubMed
    68. Tate CW, Robertson AD, Zolty R, Shakar SF, Lindenfeld J, Wolfel EE, Bristow MR, Lowes BD. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). J Card Fail. 2007 Nov; 13(9):732-7. PMID: 17996821.
      View in: PubMed
    69. Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. J Card Fail. 2007 Nov; 13(9):769-73. PMID: 17996827.
      View in: PubMed
    70. Feldman AM, Oren RM, Abraham WT, Boehmer JP, Carson PE, Eichhorn E, Gilbert EM, Kao A, Leier CV, Lowes BD, Mathier MA, McGrew FA, Metra M, Zisman LS, Shakar SF, Krueger SK, Robertson AD, White BG, Gerber MJ, Wold GE, Bristow MR. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. Am Heart J. 2007 Nov; 154(5):861-9. PMID: 17967591.
      View in: PubMed
    71. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, Maxey ML, McCune SA, Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res. 2007 Jul; 48(7):1559-70. PMID: 17426348.
      View in: PubMed
    72. Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, Haubold K, Boucek MM, Ferguson D, Graw SL, Zhu X, Cavanaugh J, Sucharov CC, Long CS, Bristow MR, Lavori P, Mestroni L. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation. 2007 Mar 13; 115(10):1244-51. PMID: 17325244.
      View in: PubMed
    73. Taylor MR, Ku L, Slavov D, Cavanaugh J, Boucek M, Zhu X, Graw S, Carniel E, Barnes C, Quan D, Prall R, Lovell MA, Mierau G, Ruegg P, Mandava N, Bristow MR, Towbin JA, Mestroni L. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007; 52(10):830-5. PMID: 17899313.
      View in: PubMed
    74. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 2007 Jan 16; 115(2):204-12. PMID: 17190867.
      View in: PubMed
    75. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006 Dec 19; 114(25):2766-72. PMID: 17159063.
      View in: PubMed
    76. Bush EW, Hood DB, Papst PJ, Chapo JA, Minobe W, Bristow MR, Olson EN, McKinsey TA. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem. 2006 Nov 03; 281(44):33487-96. PMID: 16950785.
      View in: PubMed
    77. Bristow MR. Cardiac resynchronization therapy and adrenergic mechanisms. Am J Physiol Heart Circ Physiol. 2006 Dec; 291(6):H2590-1. PMID: 16877559.
      View in: PubMed
    78. Liggett SB, Mialet-Perez J, Thaneemit-Chen S, Weber SA, Greene SM, Hodne D, Nelson B, Morrison J, Domanski MJ, Wagoner LE, Abraham WT, Anderson JL, Carlquist JF, Krause-Steinrauf HJ, Lazzeroni LC, Port JD, Lavori PW, Bristow MR. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11288-93. PMID: 16844790.
      View in: PubMed
    79. Sucharov CC, Langer S, Bristow M, Leinwand L. Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A. Am J Physiol Cell Physiol. 2006 Nov; 291(5):C1029-37. PMID: 16822951.
      View in: PubMed
    80. Quaife RA, Chen MY, Lynch D, Badesch DB, Groves BM, Wolfel E, Robertson AD, Bristow MR, Voelkel NF. Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress. Eur J Med Res. 2006 May 05; 11(5):214-20. PMID: 16723296.
      View in: PubMed
    81. Lowes BD, Zolty R, Minobe WA, Robertson AD, Leach S, Hunter L, Bristow MR. Serial gene expression profiling in the intact human heart. J Heart Lung Transplant. 2006 May; 25(5):579-88. PMID: 16678038.
      View in: PubMed
    82. Sucharov CC, Mariner PD, Nunley KR, Long C, Leinwand L, Bristow MR. A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3):H1299-308. PMID: 16501029.
      View in: PubMed
    83. Taylor MR, Bristow MR. Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure. Novartis Found Symp. 2006; 274:73-83; discussion 83-9, 152-5, 272-6. PMID: 17019807.
      View in: PubMed
    84. Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, Ghali J, Ghali J, Barnet JH, Feldman AM, Bristow MR. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol. 2005 Dec 20; 46(12):2329-34. PMID: 16360067.
      View in: PubMed
    85. Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol. 2005 Dec 20; 46(12):2311-21. PMID: 16360064.
      View in: PubMed
    86. Xu Y, Lu L, Greyson C, Rizeq M, Nunley K, Wyatt B, Bristow MR, Long CS, Schwartz GG. The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol. 2006 May; 290(5):H1798-807. PMID: 16339839.
      View in: PubMed
    87. Lowes BD, Shakar SF, Metra M, Feldman AM, Eichhorn E, Freytag JW, Gerber MJ, Liard JF, Hartman C, Gorczynski R, Evans G, Linseman JV, Stewart J, Robertson AD, Roecker EB, Demets DL, Bristow MR. Rationale and design of the enoximone clinical trials program. J Card Fail. 2005 Dec; 11(9):659-69. PMID: 16360960.
      View in: PubMed
    88. Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail. 2005 Dec; 11(9):693-9. PMID: 16360965.
      View in: PubMed
    89. Taylor MR, Slavov D, Gajewski A, Vlcek S, Ku L, Fain PR, Carniel E, Di Lenarda A, Sinagra G, Boucek MM, Cavanaugh J, Graw SL, Ruegg P, Feiger J, Zhu X, Ferguson DA, Bristow MR, Gotzmann J, Foisner R, Mestroni L. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat. 2005 Dec; 26(6):566-74. PMID: 16247757.
      View in: PubMed
    90. Rivera DA, Bristow MR. Cardiac resynchronization--a heart failure perspective. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):16-23. PMID: 16274412.
      View in: PubMed
    91. Feldman DS, Carnes CA, Abraham WT, Bristow MR. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med. 2005 Sep; 2(9):475-83. PMID: 16265588.
      View in: PubMed
    92. Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, Bristow MR, Colucci WS, Sawyer DB. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail. 2005 Aug; 11(6):473-80. PMID: 16105639.
      View in: PubMed
    93. Carniel E, Taylor MR, Sinagra G, Di Lenarda A, Ku L, Fain PR, Boucek MM, Cavanaugh J, Miocic S, Slavov D, Graw SL, Feiger J, Zhu XZ, Dao D, Ferguson DA, Bristow MR, Mestroni L. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation. 2005 Jul 05; 112(1):54-9. PMID: 15998695.
      View in: PubMed
    94. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005 May 31; 111(21):2837-49. PMID: 15927992.
      View in: PubMed
    95. Kinugawa K, Jeong MY, Bristow MR, Long CS. Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Mol Endocrinol. 2005 Jun; 19(6):1618-28. PMID: 15831522.
      View in: PubMed
    96. Domanski M, Fleg J, Bristow M, Knox S. The effect of gender on outcome in digitalis-treated heart failure patients. J Card Fail. 2005 Mar; 11(2):83-6. PMID: 15732025.
      View in: PubMed
    97. Movsesian MA, Bristow MR. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol. 2005; 68:25-48. PMID: 16124995.
      View in: PubMed
    98. Bristow MR, Adams KF, Bauman JL, Feldman AM, Giles TD, Goldstein S, Mann DL, Talbert RL. The COMET trial. Congest Heart Fail. 2005 Jan-Feb; 11(1):39-47. PMID: 15722669.
      View in: PubMed
    99. Pittenger B, Gill EA, Holcslaw TL, Bristow MR. Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. Am J Cardiol. 2004 Dec 01; 94(11):1459-62. PMID: 15566928.
      View in: PubMed
    100. Taylor MR, Bristow MR. The emerging pharmacogenomics of the beta-adrenergic receptors. Congest Heart Fail. 2004 Nov-Dec; 10(6):281-8. PMID: 15591842.
      View in: PubMed
    101. Sucharov CC, Helmke SM, Langer SJ, Perryman MB, Bristow M, Leinwand L. The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression. Mol Cell Biol. 2004 Oct; 24(19):8705-15. PMID: 15367688.
      View in: PubMed
    102. Bristow MR, Krause-Steinrauf H, Nuzzo R, Liang CS, Lindenfeld J, Lowes BD, Hattler B, Abraham WT, Olson L, Krueger S, Thaneemit-Chen S, Hare JM, Loeb HS, Domanski MJ, Eichhorn EJ, Zelis R, Lavori P. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation. 2004 Sep 14; 110(11):1437-42. PMID: 15337700.
      View in: PubMed
    103. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004 May 20; 350(21):2140-50. PMID: 15152059.
      View in: PubMed
    104. Helmke SM, Yen CY, Cios KJ, Nunley K, Bristow MR, Duncan MW, Perryman MB. Simultaneous quantification of human cardiac alpha- and beta-myosin heavy chain proteins by MALDI-TOF mass spectrometry. Anal Chem. 2004 Mar 15; 76(6):1683-9. PMID: 15018568.
      View in: PubMed
    105. Shakar SF, Lowes BD, Lindenfeld J, Zolty R, Simon M, Robertson AD, Bristow MR, Wolfel EE. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. J Card Fail. 2004 Feb; 10(1):15-20. PMID: 14966770.
      View in: PubMed
    106. Bristow MR, Feldman AM, Adams KF, Goldstein S. Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? J Card Fail. 2003 Dec; 9(6):444-53. PMID: 14966783.
      View in: PubMed
    107. Zisman LS, Meixell GE, Bristow MR, Canver CC. Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation. 2003 Oct 07; 108(14):1679-81. PMID: 14504185.
      View in: PubMed
    108. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation. 2003 Oct 07; 108(14):1707-12. PMID: 14504186.
      View in: PubMed
    109. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003 Sep 03; 42(5):914-22. PMID: 12957443.
      View in: PubMed
    110. Sucharov CC, Mariner P, Long C, Bristow M, Leinwand L. Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter. J Biol Chem. 2003 Aug 15; 278(33):31233-9. PMID: 12754214.
      View in: PubMed
    111. Bristow MR. Microarray measurements of gene expression before and after left ventricular assist device placement. J Am Coll Cardiol. 2003 Apr 02; 41(7):1107-8. PMID: 12679208.
      View in: PubMed
    112. Linseman JV, Bristow MR. Drug therapy and heart failure prevention. Circulation. 2003 Mar 11; 107(9):1234-6. PMID: 12628939.
      View in: PubMed
    113. Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol. 2003 Mar 05; 41(5):771-80. PMID: 12628721.
      View in: PubMed
    114. Bristow M. Antiadrenergic therapy of chronic heart failure: surprises and new opportunities. Circulation. 2003 Mar 04; 107(8):1100-2. PMID: 12615784.
      View in: PubMed
    115. Abraham WT, Raynolds MV, Badesch DB, Wynne KM, Groves BM, Roden RL, Robertson AD, Lowes BD, Zisman LS, Voelkel NF, Bristow MR, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics. J Renin Angiotensin Aldosterone Syst. 2003 Mar; 4(1):27-30. PMID: 12692750.
      View in: PubMed
    116. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003 Feb 19; 289(7):871-8. PMID: 12588271.
      View in: PubMed
    117. Bohlmeyer T, Ferdensi A, Bristow MR, Takahashi S, Zisman LS. Selective activation of N-acyl-D-glucosamine 2-epimerase expression in failing human heart ventricular myocytes. J Card Fail. 2003 Feb; 9(1):59-68. PMID: 12612874.
      View in: PubMed
    118. Bohlmeyer TJ, Helmke S, Ge S, Lynch J, Brodsky G, Sederberg JH, Robertson AD, Minobe W, Bristow MR, Perryman MB. Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype. Cardiovasc Pathol. 2003 Jan-Feb; 12(1):23-31. PMID: 12598014.
      View in: PubMed
    119. Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA, Wolfel EE, Shakar SF, Ferguson D, Volkman K, Linseman JV, Quaife RA, Robertson AD, Bristow MR. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med. 2002 Nov; 8(11):750-60. PMID: 12520092.
      View in: PubMed
    120. Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol. 2002 Oct 02; 40(7):1248-58. PMID: 12383572.
      View in: PubMed
    121. Bristow MR, Long CS. Cardiotrophin-1 in heart failure. Circulation. 2002 Sep 17; 106(12):1430-2. PMID: 12234941.
      View in: PubMed
    122. Asano K, Bohlmeyer TJ, Westcott JY, Zisman L, Kinugawa K, Good M, Minobe WA, Roden R, Wolfel EE, Lindenfeld J, David Port J, Perryman MB, Clevel J, Lowes BD, Bristow MR. Altered expression of endothelin receptors in failing human left ventricles. J Mol Cell Cardiol. 2002 Jul; 34(7):833-46. PMID: 12099722.
      View in: PubMed
    123. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002 May 02; 346(18):1357-65. PMID: 11986409.
      View in: PubMed
    124. Swedberg K, Bristow MR, Cohn JN, Dargie H, Straub M, Wiltse C, Wright TJ. Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure. Circulation. 2002 Apr 16; 105(15):1797-803. PMID: 11956122.
      View in: PubMed
    125. Communal C, Colucci WS, Remondino A, Sawyer DB, Port JD, Wichman SE, Bristow MR, Singh K. Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. J Card Fail. 2002 Apr; 8(2):86-92. PMID: 12016632.
      View in: PubMed
    126. Leier CV, Silver MA, Rich MW, Eichhorn EJ, Fowler MB, Giles TD, Johnstone DE, Le Jemtel TH, Lachmann JS, Levine TB, Armstrong PW, Dec WG, Jessup M, Howlett J, Hershberger RE, Cohn JN, Adams KF, Colucci WS, Warner-Stevenson L, Hosenpud JD, Bristow MR, Pina I, Baughman KL, Binkley PF, Ventura HO, Francis GS, White M, Miller LW, Berry B, Missov E. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. Congest Heart Fail. 2002 Mar-Apr; 8(2):98-124. PMID: 11927786.
      View in: PubMed
    127. Lindenfeld J, Robertson AD, Lowes BD, Bristow MR. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers. J Am Coll Cardiol. 2001 Dec; 38(7):1950-6. PMID: 11738299.
      View in: PubMed
    128. Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol. 2001 Dec; 81(2-3):141-9. PMID: 11744130.
      View in: PubMed
    129. Leier CV, Young JB, Levine TB, Pina I, Armstrong PW, Fowler MB, Warner-Stevenson L, Cohn JN, O'Connell JB, Bristow MR, Nicklas JM, Johnstone DE, Howlett J, Ventura HO, Giles TD, Greenberg BH, Chatterjee K, Bourge RC, Yancy CW, Gottleib SS. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail. 2001 Nov-Dec; 7(6):297-308. PMID: 11828174.
      View in: PubMed
    130. Kinugawa K, Long CS, Bristow MR. Expression of TR isoforms in failing human heart. J Clin Endocrinol Metab. 2001 Oct; 86(10):5089-90. PMID: 11600594.
      View in: PubMed
    131. Port JD, Bristow MR. beta-Adrenergic receptors, transgenic mice, and pharmacological model systems. Mol Pharmacol. 2001 Oct; 60(4):629-31. PMID: 11562422.
      View in: PubMed
    132. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res. 2001 Sep 28; 89(7):591-8. PMID: 11577024.
      View in: PubMed
    133. Bristow MR, Shakar SF, Linseman JV, Lowes BD. Inotropes and beta-blockers: is there a need for new guidelines? J Card Fail. 2001 Jun; 7(2 Suppl 1):8-12. PMID: 11605160.
      View in: PubMed
    134. Loh E, Elkayam U, Cody R, Bristow M, Jaski B, Colucci WS. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. J Card Fail. 2001 Jun; 7(2):114-21. PMID: 11420762.
      View in: PubMed
    135. Asano K, Zisman LS, Yoshikawa T, Headley V, Bristow MR, Port JD. Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes. J Cardiovasc Pharmacol. 2001 Jun; 37(6):678-91. PMID: 11392464.
      View in: PubMed
    136. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001 05 31; 344(22):1659-67. PMID: 11386264.
      View in: PubMed
    137. Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med. 2001 May 03; 344(18):1358-65. PMID: 11333992.
      View in: PubMed
    138. Port JD, Bristow MR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol. 2001 May; 33(5):887-905. PMID: 11343413.
      View in: PubMed
    139. Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. J Am Coll Cardiol. 2001 May; 37(6):1692-9. PMID: 11345386.
      View in: PubMed
    140. Shakar SF, Bristow MR. Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents. Curr Cardiol Rep. 2001 May; 3(3):224-31. PMID: 11305977.
      View in: PubMed
    141. Sinagra G, Di Lenarda A, Brodsky GL, Taylor MR, Muntoni F, Pinamonti B, Carniel E, Driussi M, Bristow MR, Mestroni L. Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. Ital Heart J. 2001 Apr; 2(4):280-6. PMID: 11374497.
      View in: PubMed
    142. Freeman K, Lerman I, Kranias EG, Bohlmeyer T, Bristow MR, Lefkowitz RJ, Iaccarino G, Koch WJ, Leinwand LA. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest. 2001 Apr; 107(8):967-74. PMID: 11306600.
      View in: PubMed
    143. Schleman KA, Lindenfeld JA, Lowes BD, Bristow MR, Ferguson D, Wolfel EE, Abraham WT, Zisman LS. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. J Card Fail. 2001 Mar; 7(1):4-12. PMID: 11264544.
      View in: PubMed
    144. Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RC, Tawadrous MF, Lowes BA, Long CS, Bristow MR. Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation. 2001 Feb 27; 103(8):1089-94. PMID: 11222471.
      View in: PubMed
    145. Bristow M. Of phospholamban, mice, and humans with heart failure. Circulation. 2001 Feb 13; 103(6):787-8. PMID: 11171783.
      View in: PubMed
    146. Eichhorn EJ, Bristow MR. The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Curr Control Trials Cardiovasc Med. 2001; 2(1):20-23. PMID: 11806769.
      View in: PubMed
    147. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000 Nov 14; 102(20 Suppl 4):IV14-23. PMID: 11080127.
      View in: PubMed
    148. Bristow M. Etomoxir: a new approach to treatment of chronic heart failure. Lancet. 2000 Nov 11; 356(9242):1621-2. PMID: 11089814.
      View in: PubMed
    149. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail. 2000 Sep; 6(3):276-85. PMID: 10997756.
      View in: PubMed
    150. Lowes BD, Higginbotham M, Petrovich L, DeWood MA, Greenberg MA, Rahko PS, Dec GW, LeJemtel TH, Roden RL, Schleman MM, Robertson AD, Gorczynski RJ, Bristow MR. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Am Coll Cardiol. 2000 Aug; 36(2):501-8. PMID: 10933364.
      View in: PubMed
    151. Bristow MR. What type of beta-blocker should be used to treat chronic heart failure? Circulation. 2000 Aug 01; 102(5):484-6. PMID: 10920055.
      View in: PubMed
    152. Noori A, Lindenfeld J, Wolfel E, Ferguson D, Bristow MR, Lowes BD. Beta-blockade in adriamycin-induced cardiomyopathy. J Card Fail. 2000 Jun; 6(2):115-9. PMID: 10908085.
      View in: PubMed
    153. Bristow MR. Mechanistic and clinical rationales for using beta-blockers in heart failure. J Card Fail. 2000 Jun; 6(2 Suppl 1):8-14. PMID: 10908093.
      View in: PubMed
    154. Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 2000 May; 32(5):817-30. PMID: 10775486.
      View in: PubMed
    155. Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res. 2000 Mar 03; 86(4):386-90. PMID: 10700442.
      View in: PubMed
    156. Lowes BD, Simon MA, Tsvetkova TO, Bristow MR. Inotropes in the beta-blocker era. Clin Cardiol. 2000 Mar; 23(3 Suppl):III11-6. PMID: 10754776.
      View in: PubMed
    157. Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000 Feb 08; 101(5):558-69. PMID: 10662755.
      View in: PubMed
    158. Lindenfeld J, Lowes BD, Bristow MR. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. Ann Pharmacother. 1999 Dec; 33(12):1266-9. PMID: 10630826.
      View in: PubMed
    159. Gwathmey JK, Kim CS, Hajjar RJ, Khan F, DiSalvo TG, Matsumori A, Bristow MR. Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. Am J Physiol. 1999 May; 276(5 Pt 2):H1678-90. PMID: 10330254.
      View in: PubMed
    160. Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999 Apr 15; 83(8):1201-5. PMID: 10215284.
      View in: PubMed
    161. Quaife RA, Lynch D, Badesch DB, Voelkel NF, Lowes BD, Robertson AD, Bristow MR. Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy. J Card Fail. 1999 Mar; 5(1):46-54. PMID: 10194660.
      View in: PubMed
    162. Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, Mintze K, Pickard T, Roden R, Bristow MR, Sabbah HN, Mizrahi JL, Gromo G, King GL, Vlahos CJ. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation. 1999 Jan 26; 99(3):384-91. PMID: 9918525.
      View in: PubMed
    163. Bristow MR. Mechanisms of development of heart failure in the hypertensive patient. Cardiology. 1999; 92 Suppl 1:3-6; discussion 7-9, 20-1. PMID: 10652966.
      View in: PubMed
    164. Gerdes AM, Onodera T, Tamura T, Said S, Bohlmeyer TJ, Abraham WT, Bristow MR. New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material. J Card Fail. 1998 Dec; 4(4):343-8. PMID: 9924856.
      View in: PubMed
    165. Bristow MR, Roden RL, Lowes BD, Gilbert EM, Eichhorn EJ. The role of third-generation beta-blocking agents in chronic heart failure. Clin Cardiol. 1998 Dec; 21(12 Suppl 1):I3-13. PMID: 9853189.
      View in: PubMed
    166. Zisman LS, Asano K, Dutcher DL, Ferdensi A, Robertson AD, Jenkin M, Bush EW, Bohlmeyer T, Perryman MB, Bristow MR. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart. Circulation. 1998 Oct 27; 98(17):1735-41. PMID: 9788827.
      View in: PubMed
    167. Bristow MR. Why does the myocardium fail? Insights from basic science. Lancet. 1998 Aug; 352 Suppl 1:SI8-14. PMID: 9736474.
      View in: PubMed
    168. Bristow MR, Zisman LS, Lowes BD, Abraham WT, Badesch DB, Groves BM, Voelkel NF, Lynch DM, Quaife RA. The pressure-overloaded right ventricle in pulmonary hypertension. Chest. 1998 Jul; 114(1 Suppl):101S-106S. PMID: 9676654.
      View in: PubMed
    169. Bristow M. Carvedilol tratment of chronic heart failure: a new era. Heart. 1998 Jun; 79(Suppl 2):S31-4. PMID: 18610474.
      View in: PubMed
    170. Shakar SF, Abraham WT, Gilbert EM, Robertson AD, Lowes BD, Zisman LS, Ferguson DA, Bristow MR. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol. 1998 May; 31(6):1336-40. PMID: 9581729.
      View in: PubMed
    171. Bristow MR. Tumor necrosis factor-alpha and cardiomyopathy. Circulation. 1998 Apr 14; 97(14):1340-1. PMID: 9577943.
      View in: PubMed
    172. Abraham WT, Lowes BD, Ferguson DA, Odom J, Kim JK, Robertson AD, Bristow MR, Schrier RW. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail. 1998 Mar; 4(1):37-44. PMID: 9573502.
      View in: PubMed
    173. Quaife RA, Christian PE, Gilbert EM, Datz FL, Volkman K, Bristow MR. Effects of carvedilol on right ventricular function in chronic heart failure. Am J Cardiol. 1998 Jan 15; 81(2):247-50. PMID: 9591916.
      View in: PubMed
    174. Bristow M, Port JD. Beta-adrenergic blockade in chronic heart failure. Scand Cardiovasc J Suppl. 1998; 47:45-55. PMID: 9540133.
      View in: PubMed
    175. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol. 1997 Dec 04; 80(11A):26L-40L. PMID: 9412540.
      View in: PubMed
    176. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation. 1997 Nov 04; 96(9):2755-7. PMID: 9386129.
      View in: PubMed
    177. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997 Nov 01; 100(9):2362-70. PMID: 9410916.
      View in: PubMed
    178. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997 Nov 01; 100(9):2315-24. PMID: 9410910.
      View in: PubMed
    179. Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. J Card Fail. 1997 Sep; 3(3):173-9. PMID: 9330125.
      View in: PubMed
    180. Bristow MR, Abraham WT, Yoshikawa T, White M, Hattler BG, Crisman TS, Lowes BD, Robertson AD, Larrabee P, Gilbert EM. Second- and third-generation beta-blocking drugs in chronic heart failure. Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:291-6. PMID: 9211023.
      View in: PubMed
    181. Eichhorn EJ, Bristow MR. Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure. Am J Cardiol. 1997 Mar 15; 79(6):794-8. PMID: 9070564.
      View in: PubMed
    182. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation. 1997 Mar 04; 95(5):1193-200. PMID: 9054849.
      View in: PubMed
    183. Cohn JN, Bristow MR, Chien KR, Colucci WS, Frazier OH, Leinwand LA, Lorell BH, Moss AJ, Sonnenblick EH, Walsh RA, Mockrin SC, Reinlib L. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation. 1997 Feb 18; 95(4):766-70. PMID: 9054723.
      View in: PubMed
    184. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation. 1996 Dec 01; 94(11):2800-6. PMID: 8941105.
      View in: PubMed
    185. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 1996 Dec 01; 94(11):2817-25. PMID: 8941107.
      View in: PubMed
    186. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 1996 Dec 01; 94(11):2807-16. PMID: 8941106.
      View in: PubMed
    187. Cleland JG, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J. 1996 Nov; 17(11):1629-39. PMID: 8922910.
      View in: PubMed
    188. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 1996 Nov 01; 94(9):2285-96. PMID: 8901684.
      View in: PubMed
    189. Taylor DO, Bristow MR, O'Connell JB, Price GD, Hammond EH, Doty DB, Karwande SV, Gay WA, Jones KW, Lappé D, Renlund DG. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. J Heart Lung Transplant. 1996 Oct; 15(10):1039-46. PMID: 8913922.
      View in: PubMed
    190. Wagoner LE, Taylor DO, Olsen SL, Bristow MR, O'Connell JB, Hammond EH, Lappe DL, Renlund DG. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review. Clin Transplant. 1996 Oct; 10(5):437-43. PMID: 8930458.
      View in: PubMed
    191. Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol. 1996 Oct 01; 78(7):779-84. PMID: 8857482.
      View in: PubMed
    192. Ma H, Hammond EH, Taylor DO, Yowell RL, Bristow MR, O'Connell JB, Renlund DG. The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3). Transplantation. 1996 Jul 27; 62(2):205-10. PMID: 8755817.
      View in: PubMed
    193. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23; 334(21):1349-55. PMID: 8614419.
      View in: PubMed
    194. Pende A, Tremmel KD, DeMaria CT, Blaxall BC, Minobe WA, Sherman JA, Bisognano JD, Bristow MR, Brewer G, Port J. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem. 1996 Apr 05; 271(14):8493-501. PMID: 8626551.
      View in: PubMed
    195. Yoshikawa T, Port JD, Asano K, Chidiak P, Bouvier M, Dutcher D, Roden RL, Minobe W, Tremmel KD, Bristow MR. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J. 1996 Apr; 17 Suppl B:8-16. PMID: 8733065.
      View in: PubMed
    196. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996 Mar 01; 93(5):841-2. PMID: 8598070.
      View in: PubMed
    197. Focaccio A, Peeters G, Movsesian M, Roden R, Eki Y, Krall J, Bristow MR. Mechanism of action of OPC-8490 in human ventricular myocardium. Circulation. 1996 Feb 15; 93(4):817-25. PMID: 8641012.
      View in: PubMed
    198. Renlund DG, Taylor DO, Ensley RD, O'Connell JB, Gilbert EM, Bristow MR, Ma H, Yanowitz FG. Exercise capacity after heart transplantation: influence of donor and recipient characteristics. J Heart Lung Transplant. 1996 Jan; 15(1 Pt 1):16-24. PMID: 8820079.
      View in: PubMed
    199. White M, Yanowitz F, Gilbert EM, Larrabee P, O'Connell JB, Anderson JL, Renlund D, Mealey P, Abraham WT, Bristow MR. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol. 1995 Dec 15; 76(17):1271-6. PMID: 7503009.
      View in: PubMed
    200. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995 Dec 15; 92(12):3593-612. PMID: 8521589.
      View in: PubMed
    201. Gilbert EM, Hershberger RE, Wiechmann RJ, Movsesian MA, Bristow MR. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. Chest. 1995 Dec; 108(6):1524-32. PMID: 7497755.
      View in: PubMed
    202. Jaggers J, Fullerton DA, Campbell DN, Andrea B, Jones SD, Brown JM, Wolfel EE, Lindenfeld J, Grover FL, Bristow MR. Cardiac allograft failure: successful use of biventricular assist device. Ann Thorac Surg. 1995 Nov; 60(5):1409-11. PMID: 8526640.
      View in: PubMed
    203. Bristow MR, Abraham WT. Anti-adrenergic effects of angiotensin converting enzyme inhibitors. Eur Heart J. 1995 Nov; 16 Suppl K:37-41. PMID: 8869134.
      View in: PubMed
    204. Bristow MR, Gilbert EM. Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure. Eur Heart J. 1995 Jul; 16 Suppl F:20-31. PMID: 8521881.
      View in: PubMed
    205. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995 May; 25(6):1225-31. PMID: 7722114.
      View in: PubMed
    206. Deisher TA, Ginsburg R, Fowler MB, Billingham ME, Bristow MR. Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats. Am J Cardiovasc Pathol. 1995; 5(1):79-88. PMID: 8838159.
      View in: PubMed
    207. Abraham WT, Raynolds MV, Gottschall B, Badesch DB, Wynne KM, Groves BM, Lowes BD, Bristow MR, Perryman MB, Voelkel NF. Importance of angiotensin-converting enzyme in pulmonary hypertension. Cardiology. 1995; 86 Suppl 1:9-15. PMID: 7614507.
      View in: PubMed
    208. Hunt SA, Bristow MR, Kubo SH, O'Connell JB, Young JB. Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 8: training in heart failure and transplantation. J Am Coll Cardiol. 1995 Jan; 25(1):29-31. PMID: 7798519.
      View in: PubMed
    209. Shaddy RE, Olsen SL, Bristow MR, Taylor DO, Bullock EA, Tani LY, Renlund DG. Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients. Am Heart J. 1995 Jan; 129(1):197-9. PMID: 7817916.
      View in: PubMed
    210. Abraham WT, Lowes BD, White M, Ferguson DA, Scheffel CA, Wolfel EE, Lindenfeld J, Bristow MR. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure. J Card Fail. 1994 Oct; 1(1):57-62. PMID: 9420633.
      View in: PubMed
    211. Taylor DO, Bristow MR, O'Connell JB, Ensley RD, Olsen SL, Hammond EH, Wagoner LE, Renlund DG. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3. Transplantation. 1994 Sep 27; 58(6):645-9. PMID: 7940682.
      View in: PubMed
    212. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1994 Jul-Aug; 13(4):S107-12. PMID: 7947865.
      View in: PubMed
    213. Bristow MR, O'Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, Orie J, Smucker ML, Marshall G, Kelly P, et al. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. Circulation. 1994 Apr; 89(4):1632-42. PMID: 7908610.
      View in: PubMed
    214. Bristow MR, Lowes BD. Low-dose inotropic therapy for ambulatory heart failure. Coron Artery Dis. 1994 Feb; 5(2):112-8. PMID: 7910094.
      View in: PubMed
    215. Bristow MR. Use of oral enoximone in pharmacologic bridging to cardiac transplantation. Z Kardiol. 1994; 83 Suppl 2:15-9. PMID: 7522381.
      View in: PubMed
    216. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993 Dec 11; 342(8885):1441-6. PMID: 7902479.
      View in: PubMed
    217. Wagoner LE, Olsen SL, Bristow MR, O'Connell JB, Taylor DO, Lappe DL, Renlund DG. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Transplantation. 1993 Dec; 56(6):1415-8. PMID: 8279012.
      View in: PubMed
    218. Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest. 1993 Dec; 92(6):2737-45. PMID: 8254027.
      View in: PubMed
    219. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993 Oct 30; 342(8879):1073-5. PMID: 8105309.
      View in: PubMed
    220. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 1993 Oct; 22(4 Suppl A):61A-71A. PMID: 8397233.
      View in: PubMed
    221. Gilbert EM, Sandoval A, Larrabee P, Renlund DG, O'Connell JB, Bristow MR. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart. Circulation. 1993 Aug; 88(2):472-80. PMID: 8393389.
      View in: PubMed
    222. Olsen SL, Renlund DG, O'Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation. 1993 Aug; 56(2):359-62. PMID: 8356591.
      View in: PubMed
    223. Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, et al. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15; 329(3):149-55. PMID: 8515787.
      View in: PubMed
    224. Deisher TA, Narita H, Zera P, Ginsburg R, Bristow MR, Billingham ME, Fowler MB, Hoffman BB. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats. J Pharmacol Exp Ther. 1993 Jul; 266(1):262-9. PMID: 8392553.
      View in: PubMed
    225. Baldwin JC, Anderson JL, Boucek MM, Bristow MR, Jennings B, Ritsch ME, Silverman NA. 24th Bethesda conference: Cardiac transplantation. Task Force 2: Donor guidelines. J Am Coll Cardiol. 1993 Jul; 22(1):15-20. PMID: 8509535.
      View in: PubMed
    226. Ensley RD, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O'Connell JB, Dunn D, Osburn L, Jones KW, Kauffman RS, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation. 1993 Jul; 56(1):75-82. PMID: 8333071.
      View in: PubMed
    227. Gilbert EM, Olsen SL, Renlund DG, Bristow MR. beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol. 1993 Mar 25; 71(9):23C-29C. PMID: 8096672.
      View in: PubMed
    228. Bristow MR. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. Am J Cardiol. 1993 Mar 25; 71(9):12C-22C. PMID: 8096671.
      View in: PubMed
    229. Olsen SL, Wagoner LE, Hammond EH, Taylor DO, Yowell RL, Ensley RD, Bristow MR, O'Connell JB, Renlund DG. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. J Heart Lung Transplant. 1993 Mar-Apr; 12(2):S135-42. PMID: 8476883.
      View in: PubMed
    230. Ratkovec RM, Hammond EH, O'Connell JB, Bristow MR, DeWitt CW, Richenbacher WE, Millar RC, Renlund DG. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch--preliminary results with plasmapheresis. Transplantation. 1992 Oct; 54(4):651-5. PMID: 1412756.
      View in: PubMed
    231. Port JD, Debellis CC, Klein J, Peeters GA, Barry WH, Bristow MR. Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells. J Pharmacol Exp Ther. 1992 Jul; 262(1):217-24. PMID: 1352549.
      View in: PubMed
    232. Hammond EH, Yowell RL, Price GD, Menlove RL, Olsen SL, O'Connell JB, Bristow MR, Doty DB, Millar RC, Karwande SV, et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S111-9. PMID: 1622989.
      View in: PubMed
    233. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992 Apr 30; 326(18):1182-6. PMID: 1313549.
      View in: PubMed
    234. Price GD, Olsen SL, Taylor DO, O'Connell JB, Bristow MR, Renlund DG. Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects. J Heart Lung Transplant. 1992 Mar-Apr; 11(2 Pt 2):403-14. PMID: 1571338.
      View in: PubMed
    235. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest. 1992 Mar; 89(3):803-15. PMID: 1311717.
      View in: PubMed
    236. Anderson FL, Port JD, Reid BB, Hanson G, Kralios AC, Hershberger RE, Bristow MR. Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol. 1992; 20(5):800-6. PMID: 1280744.
      View in: PubMed
    237. Bristow MR, Feldman AM. Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease. Basic Res Cardiol. 1992; 87 Suppl 1:15-35. PMID: 1323259.
      View in: PubMed
    238. Marks JD, Karwande SV, Richenbacher WE, Jones KW, Doty DB, Millar RC, O'Connell JB, Renlund DG, Bristow MR, Pantalos GM, et al. Perioperative mechanical circulatory support for transplantation. J Heart Lung Transplant. 1992 Jan-Feb; 11(1 Pt 1):117-28. PMID: 1531769.
      View in: PubMed
    239. Bristow MR, Larrabee P, Müller-Beckmann B, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Clin Investig. 1992; 70 Suppl 1:S105-13. PMID: 1350478.
      View in: PubMed
    240. Bristow MR, Larrabee P, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD, Müller-Beckmann B. Receptor pharmacology of carvedilol in the human heart. J Cardiovasc Pharmacol. 1992; 19 Suppl 1:S68-80. PMID: 1378154.
      View in: PubMed
    241. Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation. Circulation. 1992 Jan; 85(1):46-53. PMID: 1309447.
      View in: PubMed
    242. Feldman AM, Ray PE, Bristow MR. Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. J Mol Cell Cardiol. 1991 Dec; 23(12):1355-8. PMID: 1811054.
      View in: PubMed
    243. Richenbacher WE, Karwande SV, Shaddy RE, Renlund DG, Bristow MR, O'Connell JB, Gay WA. Cardiac transplantation in a patient with a single ventricle and transposition of the great vessels. Ann Thorac Surg. 1991 Oct; 52(4):871-3. PMID: 1929647.
      View in: PubMed
    244. Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J, et al. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991 Sep; 84(3):1024-39. PMID: 1653120.
      View in: PubMed
    245. Movsesian MA, Smith CJ, Krall J, Bristow MR, Manganiello VC. Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts. J Clin Invest. 1991 Jul; 88(1):15-9. PMID: 1647414.
      View in: PubMed
    246. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991 Jun; 83(6):1866-72. PMID: 2040039.
      View in: PubMed
    247. O'Connell JB, Gilbert EM, Renlund DG, Bristow MR. Enoximone as a bridge to heart transplantation: the Utah experience. J Heart Lung Transplant. 1991 May-Jun; 10(3):477-81. PMID: 1830222.
      View in: PubMed
    248. Hammond EH, Ensley RD, Yowell RL, Craven CM, Bristow MR, Renlund DG, O'Connell JB. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc. 1991 Apr; 23(2 Suppl 2):26-30. PMID: 2063418.
      View in: PubMed
    249. Feldman AM, Jackson DG, Bristow MR, Cates AE, Van Dop C. Immunodetectable levels of the inhibitory guanine nucleotide-binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. J Mol Cell Cardiol. 1991 Apr; 23(4):439-52. PMID: 1942080.
      View in: PubMed
    250. Hershberger RE, Feldman AM, Anderson FL, Kimball JA, Wynn JR, Bristow MR. Mr 40,000 and Mr 39,000 pertussis toxin substrates are increased in surgically denervated dog ventricular myocardium. J Cardiovasc Pharmacol. 1991 Apr; 17(4):568-75. PMID: 1711622.
      View in: PubMed
    251. Hershberger RE, Feldman AM, Bristow MR. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium. Circulation. 1991 Apr; 83(4):1343-51. PMID: 1901530.
      View in: PubMed
    252. O'Connell JB, Renlund DG, Hammond EH, Wittwer CT, Yowell RL, DeWitt CW, Jones KW, Gay WA, Menlove RL, Bristow MR. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss. J Heart Lung Transplant. 1991 Mar-Apr; 10(2):217-21; discussion 221-2. PMID: 1903303.
      View in: PubMed
    253. O'Connell JB, Bristow MR, Hammond EH, Menlove RL, Ensley RD, Ratkovec RM, Renlund DG. Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection. Transplant Proc. 1991 Feb; 23(1 Pt 2):1157-9. PMID: 1899154.
      View in: PubMed
    254. O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation. Transplantation. 1991 Feb; 51(2):438-42. PMID: 1994540.
      View in: PubMed
    255. Ensley RD, Hammond EH, Renlund DG, Yowell RL, Bristow MR, DeWitt CW, Menlove RL, Ratkovec RM, O'Connell JB. Clinical manifestations of vascular rejection in cardiac transplantation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1130-2. PMID: 1989167.
      View in: PubMed
    256. Moore CK, O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization. Transplant Proc. 1991 Feb; 23(1 Pt 2):1055-8. PMID: 1899151.
      View in: PubMed
    257. Gilbert EM, O'Connell JB, Bristow MR. Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade. Heart Vessels Suppl. 1991; 6:29-39. PMID: 1687924.
      View in: PubMed
    258. O'Connell JB, Bristow MR, Rasmussen LG, Ratkovec RM, Gay WA, Jones KW, Renlund DG. Cardiac allograft function with corticosteroid-free maintenance immunosuppression. Circulation. 1990 Nov; 82(5 Suppl):IV318-21. PMID: 2121388.
      View in: PubMed
    259. Olsen SL, O'Connell JB, Bristow MR, Renlund DG. Methotrexate as an adjunct in the treatment of persistent mild cardiac allograft rejection. Transplantation. 1990 Nov; 50(5):773-5. PMID: 2238053.
      View in: PubMed
    260. Hammond EH, Wittwer CT, Greenwood J, Knape WA, Yowell RL, Menlove RL, Craven C, Renlund DG, Bristow MR, DeWitt CW, et al. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation. 1990 Nov; 50(5):776-82. PMID: 2122559.
      View in: PubMed
    261. Bristow MR. The surgically denervated, transplanted human heart. Circulation. 1990 Aug; 82(2):658-60. PMID: 2372914.
      View in: PubMed
    262. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation. 1990 Aug; 82(2 Suppl):I12-25. PMID: 2164894.
      View in: PubMed
    263. Ratkovec RM, Wray RB, Renlund DG, O'Connell JB, Bristow MR, Gay WA, Karwande SV, Doty DB, Millar RC, Menlove RL, et al. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation. J Thorac Cardiovasc Surg. 1990 Jul; 100(1):6-12. PMID: 2366566.
      View in: PubMed
    264. Hershberger RE, Wynn JR, Sundberg L, Bristow MR. Mechanism of action of bucindolol in human ventricular myocardium. J Cardiovasc Pharmacol. 1990 Jun; 15(6):959-67. PMID: 1694919.
      View in: PubMed
    265. Moore CK, Bristow MR, Renlund DG, Rasmussen LG, O'Connell JB. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation. Transplant Proc. 1990 Jun; 22(3 Suppl 1):25-9. PMID: 2349736.
      View in: PubMed
    266. Hammond EH, Watson FS, Bristow MR, O'Connell JB, Gilbert EM, Doty DB, Renlund DG. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3). J Heart Transplant. 1990 May-Jun; 9(3 Pt 1):236-8. PMID: 2113090.
      View in: PubMed
    267. Renlund DG, O'Connell JB, Bristow MR. Strategies of immunosuppression in cardiac transplantation. Semin Thorac Cardiovasc Surg. 1990 Apr; 2(2):181-8. PMID: 2127901.
      View in: PubMed
    268. Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med. 1990 Mar; 88(3):223-9. PMID: 1968710.
      View in: PubMed
    269. Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, Hershberger RE, Murray J, Bristow MR. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation. 1990 Mar; 81(3):929-38. PMID: 1968367.
      View in: PubMed
    270. Rasmussen RP, Minobe W, Bristow MR. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Biochem Pharmacol. 1990 Feb 15; 39(4):691-6. PMID: 2154992.
      View in: PubMed
    271. Woodley SL, Renlund DG, O'Connell JB, Bristow MR. Immunosuppression following cardiac transplantation. Cardiol Clin. 1990 Feb; 8(1):83-96. PMID: 2407363.
      View in: PubMed
    272. Feldman AM, Bristow MR. The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy. Cardiology. 1990; 77 Suppl 1:1-32. PMID: 1970755.
      View in: PubMed
    273. Kantrowitz NE, Ellis AK, Bristow MR, Minobe W, Billingham ME, Harrison DC. Histamine mediates myocardial damage by an H1 mechanism independent of coronary blood flow. J Cardiovasc Pharmacol. 1990 Jan; 15(1):82-8. PMID: 1688987.
      View in: PubMed
    274. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA, Jones KW, O'Connell JB. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant. 1989 Nov-Dec; 8(6):430-43. PMID: 2693662.
      View in: PubMed
    275. Movsesian MA, Bristow MR, Krall J. Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res. 1989 Oct; 65(4):1141-4. PMID: 2551528.
      View in: PubMed
    276. Wittwer CT, Knape WA, Bristow MR, Gilbert EM, Renlund DG, O'Connell JB, DeWitt CW. The quantitative flow cytometric plasma OKT3 assay. Its potential application in cardiac transplantation. Transplantation. 1989 Sep; 48(3):533-5. PMID: 2528852.
      View in: PubMed
    277. Hershberger RE, Anderson FL, Bristow MR. Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density. Circ Res. 1989 Aug; 65(2):283-94. PMID: 2546693.
      View in: PubMed
    278. Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation. J Heart Transplant. 1989 Jul-Aug; 8(4):303-9; discussion 309-10. PMID: 2504897.
      View in: PubMed
    279. Shaddy RE, Mak C, Bristow MR. Comparative in vitro myocardial inotropic effects and in vivo hemodynamic effects of forskolin and isoproterenol in young lambs. Pediatr Res. 1989 Jun; 25(6):580-4. PMID: 2740148.
      View in: PubMed
    280. Brodde OE, Michel MC, Gordon EP, Sandoval A, Gilbert EM, Bristow MR. Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? Eur Heart J. 1989 Jun; 10 Suppl B:2-10. PMID: 2553408.
      View in: PubMed
    281. Bristow MR, Port JD, Hershberger RE, Gilbert EM, Feldman AM. The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure. Eur Heart J. 1989 Jun; 10 Suppl B:45-54. PMID: 2572420.
      View in: PubMed
    282. Renlund DG, O'Connell JB, Bristow MR. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary? J Heart Transplant. 1989 May-Jun; 8(3):191-3. PMID: 2661767.
      View in: PubMed
    283. O'Connell JB, Renlund DG, Gay WA, DeWitt CW, Hammond EH, Yowell RL, Jones KW, Karwande SV, Doty DB, Bristow MR. Efficacy of OKT3 retreatment for refractory cardiac allograft rejection. Transplantation. 1989 May; 47(5):788-92. PMID: 2655215.
      View in: PubMed
    284. Renlund DG, Bristow MR, Crandall BG, Burton NA, Doty DB, Karwande SV, Gay WA, Jones KW, Hegewald MG, Hagan ME, et al. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression. J Heart Transplant. 1989 May-Jun; 8(3):214-9; discussion 219-20. PMID: 2661771.
      View in: PubMed
    285. Feldman AM, Cates AE, Bristow MR, Van Dop C. Altered expression of alpha-subunits of G proteins in failing human hearts. J Mol Cell Cardiol. 1989 Apr; 21(4):359-65. PMID: 2501499.
      View in: PubMed
    286. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 1989 Mar; 79(3):483-90. PMID: 2537158.
      View in: PubMed
    287. O'Connell JB, Renlund DG, Bristow MR. Cardiac transplantation: emerging role of the internist/cardiologist. J Intern Med. 1989 Mar; 225(3):147-56. PMID: 2649631.
      View in: PubMed
    288. Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 1989 Mar; 35(3):295-303. PMID: 2564629.
      View in: PubMed
    289. Gilbert EM, Eiswirth CC, Mealey PC, Larrabee P, Herrick CM, Bristow MR. Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Circulation. 1989 Feb; 79(2):344-9. PMID: 2536597.
      View in: PubMed
    290. Bristow MR, Minobe W, Rasmussen R, Hershberger RE, Hoffman BB. Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther. 1988 Dec; 247(3):1039-45. PMID: 2849656.
      View in: PubMed
    291. Bristow MR, Lee HE, Gilbert EM, Renlund DG, Hegewald MG, Hershberger RE, O'Connell JB. Use of enoximone in patients awaiting cardiac transplant. Br J Clin Pract Suppl. 1988 Dec; 64:69-72. PMID: 2978503.
      View in: PubMed
    292. Renlund DG, Bristow MR, O'Connell JB. Cardiac transplantation--the need for prospective, randomized, controlled investigations. West J Med. 1988 Nov; 149(5):583-5. PMID: 3074558.
      View in: PubMed
    293. Anderson FL, Kralios AC, Hershberger R, Bristow MR. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J Cardiovasc Pharmacol. 1988 Sep; 12(3):365-71. PMID: 2464111.
      View in: PubMed
    294. Anderson FL, Kralios AC, Hershberger R, Bristow MR. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs. Am J Physiol. 1988 Sep; 255(3 Pt 2):H601-7. PMID: 2843056.
      View in: PubMed
    295. Gay WA, O'Connell JG, Burton NA, Karwande SV, Renlund DG, Bristow MR. OKT3 monoclonal antibody in cardiac transplantation. Experience with 102 patients. Ann Surg. 1988 Sep; 208(3):287-90. PMID: 3138951.
      View in: PubMed
    296. Renlund DG, Bristow MR, Lee HR, O'Connell JB. Medical aspects of cardiac transplantation. J Cardiothorac Anesth. 1988 Aug; 2(4):500-12. PMID: 17171937.
      View in: PubMed
    297. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988 Jul; 82(1):189-97. PMID: 2839545.
      View in: PubMed
    298. Bristow MR, Sandoval AB, Gilbert EM, Deisher T, Minobe W, Rasmussen R. Myocardial alpha- and beta-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? Eur Heart J. 1988 Jun; 9 Suppl H:35-40. PMID: 2844538.
      View in: PubMed
    299. Gilbert EM, Krueger SK, Murray JL, Renlund DG, O'Connell JB, Gay WA, Bristow MR. Echocardiographic evaluation of potential cardiac transplant donors. J Thorac Cardiovasc Surg. 1988 Jun; 95(6):1003-7. PMID: 3287011.
      View in: PubMed
    300. Yowell RL, Hammond EH, Bristow MR, Watson FS, Renlund DG, O'Connell JB. Acute vascular rejection involving the major coronary arteries of a cardiac allograft. J Heart Transplant. 1988 May-Jun; 7(3):191-7. PMID: 3290402.
      View in: PubMed
    301. Gilbert EM, O'Connell JB, Hammond ME, Renlund DG, Watson FS, Bristow MR. Treatment of myocarditis with OKT3 monoclonal antibody. Lancet. 1988 Apr 02; 1(8588):759. PMID: 2895275.
      View in: PubMed
    302. Wittwer CT, Bristow MR, Gilbert EM, Renlund DG, O'Connell JB, DeWitt CW. OKT3 therapy as a cause of high panel-reactive antibodies in serum using standard microcytotoxicity techniques. Transplantation. 1988 Apr; 45(4):832-4. PMID: 3282368.
      View in: PubMed
    303. Watson FS, O'Connell JB, Amber IJ, Renlund DG, Classen D, Johnston JM, Smith CB, Bristow MR. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG). J Heart Transplant. 1988 Mar-Apr; 7(2):102-5. PMID: 2835468.
      View in: PubMed
    304. Bristow MR. The beta-adrenergic receptor. Configuration, regulation, mechanism of action. Postgrad Med. 1988 Feb 29; Spec No:19-26. PMID: 2894659.
      View in: PubMed
    305. Bristow MR, Gilbert EM, O'Connell JB, Renlund DG, Watson FS, Hammond E, Lee RG, Menlove R. OKT3 monoclonal antibody in heart transplantation. Am J Kidney Dis. 1988 Feb; 11(2):135-40. PMID: 3277404.
      View in: PubMed
    306. Lurie KG, Bristow MR, Minobe WA, Masek M, Billingham ME. 6-Hydroxydopamine mediated cardiotoxicity in rabbits. Am J Cardiovasc Pathol. 1988; 2(2):181-91. PMID: 3144992.
      View in: PubMed
    307. Gilbert EM, Renlund DG, O'Connell JB, Eiswirth CC, Rothstein G, Gay WA, Bristow MR. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report. J Heart Transplant. 1987 Nov-Dec; 6(6):369-74. PMID: 3320307.
      View in: PubMed
    308. Gilbert EM, Bristow MR, Mason JW. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study. Am J Cardiol. 1987 Aug 14; 60(5):57C-62C. PMID: 2956870.
      View in: PubMed
    309. Renlund DG, Bristow MR, Burton NA, Jones KW, Karwande SV, Gay WA. Survival following cardiac transplantation--what are acceptable standards? West J Med. 1987 May; 146(5):627-30. PMID: 3296459.
      View in: PubMed
    310. Renlund DG, Bristow MR, Lybbert MR, O'Connell JB, Gay WA. Medicare-designated centers for cardiac transplantation. N Engl J Med. 1987 Apr 02; 316(14):873-6. PMID: 3547136.
      View in: PubMed
    311. Gilbert EM, Eiswirth CC, Renlund DG, Menlove RL, DeWitt CW, Freedman LA, Herrick CM, Gay WA, Bristow MR. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection. Transplant Proc. 1987 Apr; 19(2 Suppl 1):45-53. PMID: 3105140.
      View in: PubMed
    312. Renlund DG, O'Connell JB, Gilbert EM, Watson FS, Bristow MR. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. J Heart Transplant. 1987 Mar-Apr; 6(2):71-8. PMID: 3305832.
      View in: PubMed
    313. Gilbert EM, Dewitt CW, Eiswirth CC, Renlund DG, Menlove RL, Freedman LA, Herrick CM, Gay WA, Bristow MR. Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. Am J Med. 1987 Feb; 82(2):202-6. PMID: 3544838.
      View in: PubMed
    314. Bristow MR, Ginsburg R, Gilbert EM, Hershberger RE. Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart. Basic Res Cardiol. 1987; 82 Suppl 2:369-76. PMID: 2821984.
      View in: PubMed
    315. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986 Dec; 74(6):1290-302. PMID: 3022962.
      View in: PubMed
    316. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986 Sep; 59(3):297-309. PMID: 2876788.
      View in: PubMed
    317. Bristow MR, Ginsburg R. Beta 2 receptors on myocardial cells in human ventricular myocardium. Am J Cardiol. 1986 Apr 25; 57(12):3F-6F. PMID: 3010694.
      View in: PubMed
    318. Freter CE, Lee TC, Billingham ME, Chak L, Bristow MR. Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review. Am J Med. 1986 Mar; 80(3):483-5. PMID: 3513562.
      View in: PubMed
    319. Schroeder JS, Beier-Scott L, Ginsburg R, Bristow MR, McAuley BJ. Efficacy of diltiazem for medically refractory stable angina: long-term follow-up. Clin Cardiol. 1985 Sep; 8(9):480-5. PMID: 2864152.
      View in: PubMed
    320. Bristow MR, Kantrowitz NE, Ginsburg R, Fowler MB. Beta-adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol. 1985 Jul; 17 Suppl 2:41-52. PMID: 2863387.
      View in: PubMed
    321. Fowler MB, Bristow MR. Rationale for beta-adrenergic blocking drugs in cardiomyopathy. Am J Cardiol. 1985 Apr 26; 55(10):120D-124D. PMID: 2859789.
      View in: PubMed
    322. Kantrowitz NE, Bristow MR. Cardiotoxicity of antitumor agents. Prog Cardiovasc Dis. 1984 Nov-Dec; 27(3):195-200. PMID: 6387802.
      View in: PubMed
    323. Bristow MR. The adrenergic nervous system in heart failure. N Engl J Med. 1984 Sep 27; 311(13):850-1. PMID: 6472388.
      View in: PubMed
    324. Ginsburg R, Bristow MR, Davis K. Receptor mechanisms in the human epicardial coronary artery. Heterogeneous pharmacological response to histamine and carbachol. Circ Res. 1984 Sep; 55(3):416-21. PMID: 6467531.
      View in: PubMed
    325. Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W. Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest. 1984 Jul; 74(1):212-23. PMID: 6330174.
      View in: PubMed
    326. Bristow MR, Ginsburg R, Laser JA, McAuley BJ, Minobe W. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites. Br J Pharmacol. 1984 Jun; 82(2):309-20. PMID: 6329392.
      View in: PubMed
    327. Bristow MR. Myocardial beta-adrenergic receptor downregulation in heart failure. Int J Cardiol. 1984 May; 5(5):648-52. PMID: 6325351.
      View in: PubMed
    328. Tsujimoto G, Bristow MR, Hoffman BB. Identification of alpha 1 adrenergic receptors in rabbit aorta with [125I] BE2254. Life Sci. 1984 Feb 13; 34(7):639-46. PMID: 6321870.
      View in: PubMed
    329. Ginsburg R, Bristow MR, Davis K, Dibiase A, Billingham ME. Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation. 1984 Feb; 69(2):430-40. PMID: 6690108.
      View in: PubMed
    330. Bristow MR, Billingham ME, Mason JW. Adriamycin cardiotoxicity. Am J Cardiol. 1984 Jan 01; 53(1):263-4. PMID: 6691272.
      View in: PubMed
    331. Torti FM, Bristow MR, Howes AE, Aston D, Stockdale FE, Carter SK, Kohler M, Brown BW, Billingham ME. Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. Ann Intern Med. 1983 Dec; 99(6):745-9. PMID: 6651020.
      View in: PubMed
    332. McKillop JH, Bristow MR, Goris ML, Billingham ME, Bockemuehl K. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J. 1983 Nov; 106(5 Pt 1):1048-56. PMID: 6637763.
      View in: PubMed
    333. Bristow MR, Kantrowitz NE, Harrison WD, Minobe WA, Sageman WS, Billingham ME. Mediation of subacute anthracycline cardiotoxicity in rabbits by cardiac histamine release. J Cardiovasc Pharmacol. 1983 Nov-Dec; 5(6):913-9. PMID: 6196562.
      View in: PubMed
    334. Ginsburg R, Bristow MR, Billingham ME, Stinson EB, Schroeder JS, Harrison DC. Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J. 1983 Sep; 106(3):535-40. PMID: 6308994.
      View in: PubMed
    335. Lurie KG, Bristow MR, Reitz BA. Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):195-201. PMID: 6308358.
      View in: PubMed
    336. Schroeder JS, Lamb IH, Bristow MR, Ginsburg R, Hung J, McAuley BJ. Prevention of cardiovascular events in variant angina by long-term diltiazem therapy. J Am Coll Cardiol. 1983 Jun; 1(6):1507-11. PMID: 6853903.
      View in: PubMed
    337. Ginsburg R, Esserman LJ, Bristow MR. Myocardial performance and extracellular ionized calcium in a severely failing human heart. Ann Intern Med. 1983 May; 98(5 Pt 1):603-6. PMID: 6133487.
      View in: PubMed
    338. Bristow MR. Toxic cardiomyopathy due to doxorubicin. Hosp Pract (Off Ed). 1982 Dec; 17(12):101-8, 110-1. PMID: 6815051.
      View in: PubMed
    339. Kantrowitz NE, Bristow MR, Minobe WA, Billingham ME, Harrison DC. Histamine-mediated myocardial damage in rabbits. J Mol Cell Cardiol. 1982 Sep; 14(9):551-5. PMID: 7175954.
      View in: PubMed
    340. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22; 307(4):205-11. PMID: 6283349.
      View in: PubMed
    341. Bristow MR, Lopez MB, Mason JW, Billingham ME, Winchester MA. Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer. 1982 Jul 01; 50(1):32-41. PMID: 7083125.
      View in: PubMed
    342. Lurie KG, Billingham ME, Masek MA, Ginsburg R, Bristow MR, Harrison D, Reitz BA. Ultrastructural and functional studies on prolonged myocardial preservation in an experimental heart transplant model. J Thorac Cardiovasc Surg. 1982 Jul; 84(1):122-9. PMID: 7045539.
      View in: PubMed
    343. Bristow MR, Cubicciotti R, Ginsburg R, Stinson EB, Johnson C. Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol. 1982 May; 21(3):671-9. PMID: 6125879.
      View in: PubMed
    344. Clusin WT, Bristow MR, Baim DS, Schroeder JS, Jaillon P, Brett P, Harrison DC. The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dog. Circ Res. 1982 Apr; 50(4):518-26. PMID: 7067059.
      View in: PubMed
    345. Bristow MR, Ginsburg R, Kantrowitz NE, Baim DS, Rosenbaum JT. Coronary spasm associated with urticaria: report of a case mimicking anaphylaxis. Clin Cardiol. 1982 Mar; 5(3):238-40. PMID: 7083649.
      View in: PubMed
    346. Schroeder JS, Lamb IH, Ginsburg R, Bristow MR, Hung J. Diltiazem for long-term therapy of coronary arterial spasm. Am J Cardiol. 1982 Feb 18; 49(3):533-7. PMID: 7058764.
      View in: PubMed
    347. Clusin WT, Bristow MR, Karagueuzian HS, Katzung BG, Schroeder JS. Do calcium-dependent ionic currents mediate ischemic ventricular fibrillation? Am J Cardiol. 1982 Feb 18; 49(3):606-12. PMID: 6277181.
      View in: PubMed
    348. Bristow MR, Ginsburg R, Harrison DC. Histamine and the human heart: the other receptor system. Am J Cardiol. 1982 Jan; 49(1):249-51. PMID: 7032271.
      View in: PubMed
    349. Ginsburg R, Bristow MR, Kantrowitz N, Baim DS, Harrison DC. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J. 1981 Nov; 102(5):819-22. PMID: 6795908.
      View in: PubMed
    350. Bristow MR, Mason JW, Billingham ME, Daniels JR. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J. 1981 Oct; 102(4):709-18. PMID: 7282516.
      View in: PubMed
    351. Ginsburg R, Stinson EB, Bristow MR, Schroeder JS. Coronary-artery spasm after revascularization. N Engl J Med. 1981 Sep 17; 305(12):699. PMID: 6973694.
      View in: PubMed
    352. Bristow MR, Minobe WA, Billingham ME, Marmor JB, Johnson GA, Ishimoto BM, Sageman WS, Daniels JR. Anthracycline-associated cardiac and renal damage in rabbits. Evidence for mediation by vasoactive substances. Lab Invest. 1981 Aug; 45(2):157-68. PMID: 6167794.
      View in: PubMed
    353. Bristow MR, Sageman WS, Scott RH, Billingham ME, Bowden RE, Kernoff RS, Snidow GH, Daniels JR. Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release. J Cardiovasc Pharmacol. 1980 Sep-Oct; 2(5):487-515. PMID: 6157945.
      View in: PubMed
    354. Ginsburg R, Bristow MR, Harrison DC, Stinson EB. Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists. Chest. 1980 Jul; 78(1 Suppl):180-6. PMID: 6772384.
      View in: PubMed
    355. Ginsburg R, Bristow MR, Stinson EB, Harrison DC. Histamine receptors in the human heart. Life Sci. 1980 Jun 30; 26(26):2245-9. PMID: 6105606.
      View in: PubMed
    356. Bristow MR. Testing for doxorubicin cardiotoxicity. N Engl J Med. 1979 Jun 14; 300(24):1393. PMID: 440372.
      View in: PubMed
    357. Bristow MR, Thompson PD, Martin RP, Mason JW, Billingham ME, Harrison DC. Early anthracycline cardiotoxicity. Am J Med. 1978 Nov; 65(5):823-32. PMID: 707541.
      View in: PubMed
    358. Mason JW, Bristow MR, Billingham ME, Daniels JR. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep. 1978 Jun; 62(6):857-64. PMID: 667859.
      View in: PubMed
    359. Billingham ME, Mason JW, Bristow MR, Daniels JR. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep. 1978 Jun; 62(6):865-72. PMID: 667860.
      View in: PubMed
    360. Bristow MR, Billingham ME, Mason JW, Daniels JR. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep. 1978 Jun; 62(6):873-9. PMID: 667861.
      View in: PubMed
    361. Bristow MR, Mason JW, Billingham ME, Daniels JR. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med. 1978 Feb; 88(2):168-75. PMID: 626445.
      View in: PubMed
    362. Bristow MR, Daniels JR, Kernoff RS, Harrison DC. Effect of D600, practolol, and alterations in magnesium on ionized calcium concentration-response relationships in the intact dog heart. Circ Res. 1977 Oct; 41(4):574-81. PMID: 902364.
      View in: PubMed
    363. Bristow MR, Schwartz HD, Binetti G, Harrison DC, Daniels JR. Ionized calcium and the heart. Elucidation of in vivo concentration-response relationships in the open-chest dog. Circ Res. 1977 Oct; 41(4):565-74. PMID: 902363.
      View in: PubMed
    364. Bristow MR, Green RD. Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium. Eur J Pharmacol. 1977 Oct 01; 45(3):267-79. PMID: 21800.
      View in: PubMed
    365. Billingham ME, Bristow MR, Glatstein E, Mason JW, Masek MA, Daniels JR. Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol. 1977 Mar; 1(1):17-23. PMID: 602969.
      View in: PubMed
    366. Bristow M, Green RD. A quantitative study of beta-adrenergic receptors in rabbit atria. Eur J Pharmacol. 1970 Sep 01; 12(1):120-3. PMID: 4394343.
      View in: PubMed
    367. Bristow M. Vasodilation in treatment of hypertension. N Engl J Med. 1970 May 07; 282(19):1102. PMID: 4392413.
      View in: PubMed
    368. Bristow M, Sherrod TR, Green RD. Analysis of beta receptor drug interactions in isolated rabbit atrium, aorta, stomach and trachea. J Pharmacol Exp Ther. 1970 Jan; 171(1):52-61. PMID: 4391468.
      View in: PubMed
    Bristow's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)